Regulatory Information Management Market Insights Covering Market Dynamics and Competitive Scenario through 2029
August 19, 2019 by Amanpreet
The regulatory information management (RIM) market is envisaged to surpass revenues worth US$ 893 Mn in 2019, according to a recent study by Fact.MR. Growing requirement for seamless regulatory submission data and product labeling management across enterprises is providing a fillip to the installation of regulatory information management software. Dire need of companies to alleviate the ‘time to market’ (TTM) cycle is a significant factor providing an impetus to the growth of regulatory information management market.
Report Summary of the Report: https://www.factmr.com/report/3741/regulatory-information-management-market
The study opines that as the regional and international authorities continue to set the ever-changing reporting requirements, the call for proper RIM solution deployment will grow louder. The demand for regulatory information management solutions will be further assisted by the growing number of firms realizing the significance of the strategic role of product data.
According to the report, deployment of regulatory information management software for health authority management will remain high across pharmaceuticals industry, with the global deployment across different verticals estimated to surpass US$ 252 Mn in 2019. Reduction in manual errors in regulatory processes, along with an easy access to dossier, continues to contribute to the growth of the regulatory information management market.
A wide range of small and medium enterprises are implementing a broad regulatory information management platform to eliminate various data hand-offs and for better overall data quality and visibility. As per the study, global deployment of regulatory information management across small and medium enterprises exceeded US$ 513 Mn in 2018, and will witness a robust yearly growth in 2019 and ahead.
Get the Sample PDF of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=3741
The study also highlights that the deployment of regulatory information management software is growing at a steady pace, driven by a plethora of categories. However, health authority management will particularly remain an attractive category. Furthermore, the demand for unified regulatory information management software will remain sustained in health authority management, as it enables effective control of data for a leaner, higher quality submission. This further translates to a more efficient review process for authorities and builds credibility, potentially reducing regulatory burden of enterprises, and thereby augmenting the deployment of unified regulatory information management platforms.
The study opines that compliance modernization is no longer optional, with international authorities continuously setting new and often arduous reporting requirements. In view of the constantly changing regulatory paradigms, enterprises with different verticals, such as pharmaceuticals, medical devices, and nutraceuticals are expecting more from the software that helps them log and keep track of everything. This has further accelerated the trend of new product development (NPD) in the regulatory information management market, finds the study. Additionally, sensing the pain points related to disparate systems, exacerbated by IDMP (Identification of Medicinal Products) requirements, more players in regulatory information management market are drifting to unified platforms through NPD.
Report Customization can be done at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=3741
Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.
Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.
The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.